ALNY

NASDAQ · Biotechnology

Alnylam Pharmaceuticals Inc

Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$330.87

+14.78 (+4.68%)

Analyst Consensus

Strong Buy

Analysts

Very High

Coverage

Buy 28 78%

Hold 8 22%

Sell 0 0%

Price Target

Analyst Price Target -69.1% upside

Low Target $75.08

Average Target $102.31

High Target $108.98

Current Price $330.87

Current
$330.87

Target
$102.31

$75.08 $102.31 avg $108.98

Scenario Analysis

Bear Case

$75.08

-77.3%

Low target

Base Case

$102.31

-69.1%

Avg target

Bull Case

$108.98

+-67.1%

High target

Risk/Reward

0.9x

Unfavorable

Price in Context

52-Week High

$495.55

-33.2% from high

52-Week Low

$205.87

+60.7% from low

50-Day SMA

$371.56

-11.0% vs SMA

200-Day SMA

$388.35

-14.8% vs SMA

RSI (14)

46.4

Neutral

Target vs 52W High

$102.31

-79.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+18.4%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.8%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+160.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-1.8%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.1%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-28.5%